--2025/Q1-- / 205.550K--
--2024/Q4-- / 53.660K--
--2024/Q343.000K / 205.400K--
--2024/Q2111.000K / 176.330K--
--2024/Q1529.000K / 0.000--
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
CGON CG Oncology
- 28.450
- -0.820-2.80%
Close Dec 18 16:00 ET
- 29.800
- +1.350+4.75%
Pre 06:32 ET
2.13BMarket Cap-24.53P/E (TTM)
30.000High27.980Low1.33MVolume29.080Open29.270Pre Close38.08MTurnover2.53%Turnover RatioLossP/E (Static)74.93MShares50.23052wk High3.97P/B1.49BFloat Cap25.77052wk Low--Dividend TTM52.50MShs Float50.230Historical High--Div YieldTTM6.90%Amplitude25.770Historical Low28.693Avg Price1Lot Size
CG Oncology Key Stats
CG Oncology Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
CG Oncology Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data